565
Participants
Start Date
January 25, 2022
Primary Completion Date
April 11, 2023
Study Completion Date
April 17, 2023
VI-0521
Phentermine/Topiramate Top Dose 15 mg/92 mg capsule
Phentermine
Phentermine 30 mg capsule
Placebo
Inactive oral capsule
Clinical Site, Washington D.C.
Clinical Site, Port Orange
Clinical Site, Norfolk
Clinical Site, Cary
Clinical Site, Columbia
Clinical Site, Coral Gables
Clinical Site, Miami
Clinical Site, Anniston
Clinical Site, Mobile
Clinical Site, Knoxville
Clinical Site, Louisville
Clinical Site, Lexington
Clinical Site, Brownsburg
Clinical Site, Evansville
Clinical Site, Butte
Clinical Site, Kansas City
Clinical Site, Wichita
Clinical Site, Baton Rouge
Clinical Site, North Richland Hills
Clinical Site, Friendswood
Clinical Site, San Antonio
Clinical site, Salt Lake City
Clinical Site, Long Beach
Clinical Site, Upland
Clinical Site, Spring Valley
Clinical Site, Lincoln
Clinical Site, Sacramento
Clinical Site, Eugene
VIVUS LLC
INDUSTRY